UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

Temporal dynamics in viral shedding and transmissibility of COVID-19

Nature medicine, 2020-05, Vol.26 (5), p.672-675

2020

Link zum Volltext

Verfügbarkeit prüfen

A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract

Cellular & molecular immunology, 2020-11, Vol.17 (11), p.1119-1125

2020

Link zum Volltext

Verfügbarkeit prüfen

Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients

PloS one, 2015-07, Vol.10 (7), p.e0133800

2015

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19

Nature medicine, 2020-09, Vol.26 (9), p.1491-1493

2020

Link zum Volltext

Verfügbarkeit prüfen

慢加急性肝衰竭合并感染的诊治

临床肝胆病杂志, 2019-11, Vol.35 (11), p.2596-2599

2019

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway

Mediators of Inflammation, 2015-01, Vol.2015, p.508989-5

2015

Link zum Volltext

Verfügbarkeit prüfen

Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China

Infectious diseases and therapy, 2023-11, Vol.12 (11), p.2595-2609

2023

Link zum Volltext

Verfügbarkeit prüfen

艾尔巴韦/格拉瑞韦治疗基因1型慢性丙型肝炎效果的真实世界研究

临床肝胆病杂志, 2020-12, Vol.36 (12), p.2700-2704

2020

Link zum Volltext

Verfügbarkeit prüfen

The salt marsh vegetation dynamics analysis with GeoCA-wetland-landscape

2010 18th International Conference on Geoinformatics, 2010, p.1-6

Yujuan Guan

2010

Link zum Volltext
IEEE_Xplore

Real-world effectiveness and safety of OBT/PTV/r and dasabuvir for patients with chronic HCV genotype 1b infection in China: A multicenter prospective observational study

Liver research, 2020-09, Vol.4 (3), p.153-158

2020

Link zum Volltext

Verfügbarkeit prüfen

24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial

PloS one, 2015-10, Vol.10 (10), p.e0140853-e0140853

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C

Journal of clinical and translational hepatology, 2019-09, Vol.7 (3), p.221-225

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial

Med (New York, N.Y. : Online), 2020-12, Vol.1 (1), p.105-113.e4

2020

Link zum Volltext

Verfügbarkeit prüfen

Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients

Virus research, 2021-09, Vol.302, p.198453-198453, Article 198453

2021

Link zum Volltext

Verfügbarkeit prüfen

Data Mining Based on the Rough Analysis and the Application in the Telecommunication Network Quality Evaluation

Telkomnika, 2016-09, Vol.14 (3A), p.313

2016

Link zum Volltext

Verfügbarkeit prüfen

A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection

Clinical infectious diseases, 2018-01, Vol.66 (1), p.29-35

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic roles of KL‐6 in disease severity and lung injury in COVID‐19 patients: A longitudinal retrospective analysis

Journal of medical virology, 2021-04, Vol.93 (4), p.2505-2512

2021

Link zum Volltext

Verfügbarkeit prüfen

DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation

Journal of virology, 2022-07, Vol.96 (13), p.e0058522-e0058522

2022

Link zum Volltext

Verfügbarkeit prüfen

Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B

Journal of viral hepatitis, 2019-07, Vol.26 (S1), p.77-84

2019

Link zum Volltext

Verfügbarkeit prüfen

WED-412 Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update

Journal of hepatology, 2024-06, Vol.80, p.S803-S803

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in Guangdong, China

Journal of medical virology, 2022-09, Vol.94 (9), p.4459-4469

2022

Link zum Volltext

Verfügbarkeit prüfen

SAT-193 - Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

Journal of hepatology, 2023-06, Vol.78, p.S1165-S1166

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

Journal of hepatology, 2023-06, Vol.78, p.S1165-S1166

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT-174 - Vebicorvir, entecavir, and pegylated interferon in patients with hepatitis B e antigen positive chronic hepatitis B virus infection: findings from a phase 2, randomized open-label study in China

Journal of hepatology, 2023-06, Vol.78, p.S1153-S1154

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Temporal dynamics in viral shedding and transmissibility of COVID-19

A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract

Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients

Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19

慢加急性肝衰竭合并感染的诊治

Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway

Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China

艾尔巴韦/格拉瑞韦治疗基因1型慢性丙型肝炎效果的真实世界研究

The salt marsh vegetation dynamics analysis with GeoCA-wetland-landscape

Real-world effectiveness and safety of OBT/PTV/r and dasabuvir for patients with chronic HCV genotype 1b infection in China: A multicenter prospective observational study

24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial

Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial

Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients

Data Mining Based on the Rough Analysis and the Application in the Telecommunication Network Quality Evaluation

A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection

Prognostic roles of KL‐6 in disease severity and lung injury in COVID‐19 patients: A longitudinal retrospective analysis

DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation

Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B

WED-412 Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update

SAT-198 ASC41, a selective THRβ agonist significantly reduces liver fat and ALT in biopsy-confirmed MASH patients after 12-week treatment: an interim analysis of a 52-week serial liver biopsy study

Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in Guangdong, China

SAT-193 - Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

SAT-174 - Vebicorvir, entecavir, and pegylated interferon in patients with hepatitis B e antigen positive chronic hepatitis B virus infection: findings from a phase 2, randomized open-label study in China

Suchergebnisse filtern